The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 26, 2017
Filed:
Apr. 03, 2013
Applicant:
Intervet Inc., Summit, NJ (US);
Inventors:
Keith Freehauf, Stockton, NJ (US);
Niki Waldron, Piscataway, NJ (US);
Jürgen Lutz, Wiesbaden, DE;
Frank Guerino, Monroe Township, NJ (US);
Assignee:
Intervet Inc., Madison, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/42 (2006.01); A01N 43/80 (2006.01); A61K 31/7048 (2006.01); A61K 31/35 (2006.01); A61K 31/422 (2006.01); A61K 47/38 (2006.01); A61K 47/22 (2006.01); A61K 47/16 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 47/12 (2006.01); B29C 37/00 (2006.01); A61K 47/18 (2017.01); A61K 9/14 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 9/48 (2006.01); A61K 9/50 (2006.01); A61K 9/51 (2006.01); B29L 31/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/42 (2013.01); A61K 9/0056 (2013.01); A61K 9/145 (2013.01); A61K 9/1617 (2013.01); A61K 9/2013 (2013.01); A61K 9/282 (2013.01); A61K 9/4858 (2013.01); A61K 9/5015 (2013.01); A61K 9/5123 (2013.01); A61K 31/35 (2013.01); A61K 31/422 (2013.01); A61K 31/7048 (2013.01); A61K 45/06 (2013.01); A61K 47/12 (2013.01); A61K 47/16 (2013.01); A61K 47/18 (2013.01); A61K 47/22 (2013.01); A61K 47/38 (2013.01); B29C 37/0003 (2013.01); B29L 2031/753 (2013.01);
Abstract
A solid oral pharmaceutical composition for delivery of a pharmaceutically acceptable active ingredient to an animal where the composition comprises an isoxazoline compound, a solvent and an excipient, a process for the manufacture of such solid oral pharmaceutical composition and a method of controlling a parasite infection administering such solid oral pharmaceutical composition.